Celltrion Inc
-
Takeda Completes Sale of Select OTC and Non-Core Assets to Celltrion in Asia Pacific
Osaka, Japan: Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced the completion of its previously-announced sale of a portfolio of…
Read More »